8-K: Femasys Averts Nasdaq Delisting with Equity Boost

Femasys Inc. believes it has regained compliance with Nasdaq's minimum stockholders' equity requirement, averting a potential delisting after a recent $8.0 million capital raise and warrant exercises.

Summary

• Femasys Inc. previously received a Nasdaq notice on May 19, 2025, for failing to meet the minimum $35.0 million Market Value of Listed Securities (MVLS) requirement.
• The company also did not meet alternative Nasdaq listing standards, including $2.5 million in stockholders' equity or $500,000 in net income.
• Following an $8.0 million underwritten offering of common stock, pre-funded warrants, and warrants (disclosed August 27, 2025) and subsequent warrant exercises, Femasys estimates its pro forma stockholders' equity as of October 15, 2025, to be approximately $5.2 million.
• This pro forma stockholders' equity of $5.2 million meets Nasdaq's minimum $2.5 million requirement for continued listing.
• Nasdaq will continue to monitor the company's compliance, and failure to evidence compliance in the next periodic report could still lead to delisting.

Sentiment

Score: 7

Explanation: The company successfully addressed a critical delisting threat by raising capital and improving its stockholders' equity position, which is a significant positive. However, the compliance is based on pro forma data and remains subject to ongoing Nasdaq monitoring, introducing a degree of uncertainty.

Positives

• The company believes it has regained compliance with Nasdaq's minimum stockholders' equity requirement of $2.5 million, reporting approximately $5.2 million on a pro forma basis as of October 15, 2025.
• The successful $8.0 million underwritten offering and subsequent warrant exercises contributed to the improved financial position.
• Averted immediate delisting from The Nasdaq Capital Market.

Negatives

• The company previously failed to meet Nasdaq's minimum $35.0 million Market Value of Listed Securities (MVLS) requirement.
• The company previously failed to meet alternative Nasdaq listing standards, including $2.5 million in stockholders' equity or $500,000 in net income.
• Nasdaq will continue to monitor compliance, and future non-compliance could still result in delisting.
• The company's compliance is based on "pro forma financial data" and "belief," indicating it is not yet officially confirmed by Nasdaq or a full financial report.

Risks

• Risk of future delisting if the company fails to maintain compliance with Nasdaq's continued listing standards, particularly the stockholders' equity requirement, as monitored by Nasdaq.
• Actual results, performance, or achievements could differ materially from forward-looking statements regarding stockholders' equity.

Future Outlook

Nasdaq will continue to monitor the company's ongoing compliance with the stockholders' equity requirement. If the company does not evidence compliance at the time of its next periodic report, it may be subject to delisting.

Management Comments

• The Company believes that, after taking into account the previously disclosed underwritten offering of common stock, pre-funded warrants and warrants with gross proceeds of $8.0 million as further detailed in a Form 8-K filed on August 27, 2025 and subsequent warrant exercises, and based on pro forma financial data available to the Company, the Companys stockholders equity as of October 15, 2025 would have been approximately $5.2 million on a pro forma basis, which meets the minimum of $2.5 million in stockholders equity requirement for continued listing on The Nasdaq Capital Market.

Industry Context

This filing highlights the ongoing challenges smaller public companies face in maintaining compliance with exchange listing standards, particularly during periods of market volatility or operational challenges. Meeting minimum financial thresholds like stockholders' equity is crucial for investor confidence and access to capital markets.

Stakeholder Impact

• Shareholders: Positive impact by averting immediate delisting, preserving liquidity and investment value on Nasdaq. However, the capital raise likely involved dilution.
• Employees: Stability in the company's listing status may reduce uncertainty.
• Creditors: Improved financial standing (higher equity) could be viewed positively.

Next Steps

• Nasdaq will continue to monitor the company's ongoing compliance with the stockholders' equity requirement.
• The company must evidence compliance in its next periodic report to avoid potential delisting.

Key Dates

Recommendation

The company successfully addressed a critical delisting threat by raising $8.0 million and increasing its pro forma stockholders' equity to $5.2 million, exceeding Nasdaq's $2.5 million minimum. This averts immediate delisting and provides a temporary reprieve. However, the company previously failed multiple listing standards, and Nasdaq will continue to monitor its compliance. The capital raise, while necessary, likely involved dilution. Investors should hold to observe sustained compliance and fundamental business improvements rather than making a strong buy or sell decision based solely on this compliance update.

Keywords

Femasys, FEMY, Nasdaq, delisting, stockholders' equity, capital raise, compliance, listing standards, 8-K